EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudieOpen Access

Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient Setting

Yogesh N V Reddy iD, Atsushi Tada, Masaru Obokata iD, Rickey E Carter iD, David M Kaye iD, M Louis Handoko iD, Mads J Andersen iD, Kavita Sharma iD, Ryan J Tedford iD, Margaret M Redfield iD, Barry A Borlaug iD

Circulation · 08.04.2025 · 151 (14) · 976-989

DOI: 10.1161/circulationaha.124.072156 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation, erschienen am 08.04.2025. Verfasst von Yogesh N V Reddy und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.N.V.R., A.T., M.M.R., B.A.B.). Hauptthemen laut MEDLINE: Heart Failure, Stroke Volume, Natriuretic Peptide, Brain, Peptide Fragments. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Plasma NT-proBNP (N-terminal pro-B-type natriuretic peptide) is commonly used to diagnose heart failure with preserved ejection fraction (HFpEF), but its diagnostic performance in the ambulatory/outpatient setting is unknown because previous studies lacked objective reference standards. METHODS: Among patients with chronic dyspnea, diagnosis of HFpEF or noncardiac dyspnea was determined conclusively by exercise catheterization in a derivation cohort (n=414), multicenter validation cohort 1 (n=560), validation cohort 2 (n=207), and a nonobese Japanese validation cohort 3 (n=77). Optimal NT-proBNP cut points for HFpEF rule out (optimizing sensitivity) and rule in (optimizing specificity) were derived and tested, stratified by obesity and atrial fibrillation. Derived cut points were tested in 3 additional validation cohorts (cohorts 4–6) in whom HFpEF was diagnosed by resting catheterization only (n=260), previous hospitalization for heart failure (n=447), or exercise echocardiography (n=517), respectively. RESULTS: Current recommended rule-out NT-proBNP threshold

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureStroke VolumeNatriuretic Peptide, BrainPeptide FragmentsAmbulatory CareEvidence-Based MedicineHumansMaleFemaleAgedMiddle AgedOutpatientsChronic DiseaseBiomarkersAged, 80 and overCohort StudiesDyspnea

Stichwörter der Autor:innen

exerciseheart failurehemodynamicsnatriuretic peptidespro-brain natriuretic peptide

Substanzen

Natriuretic Peptide, Brainpro-brain natriuretic peptide (1-76)Peptide FragmentsBiomarkers

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.N.V.R., A.T., M.M.R., B.A.B.).
  • Department of Cardiology, Gunma University Graduate School of Medicine, Maebashi, Japan (M.O.).
  • Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL (R.E.C.).
  • Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia (D.M.K.).
  • Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, Netherlands (M.L.H.).
  • Department of Cardiology, Aarhus University Hospital, Denmark (M.J.A.).

ORCID-Profile: Yogesh N V Reddy, Masaru Obokata, Rickey E Carter, David M Kaye, M Louis Handoko, Mads J Andersen, Kavita Sharma, Ryan J Tedford, Margaret M Redfield, Barry A Borlaug

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Reddy, Y. N. V., Tada, A., Obokata, M., Carter, R. E., Kaye, D. M., Handoko, M. L., Andersen, M. J., Sharma, K., Tedford, R. J., Redfield, M. M., & Borlaug, B. A. (2025). Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient Setting. Circulation, 151(14), 976-989. https://doi.org/10.1161/circulationaha.124.072156

Vancouver

Reddy YNV, Tada A, Obokata M, Carter RE, Kaye DM, Handoko ML, et al. Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient Setting. Circulation. 2025;151(14):976-989. doi:10.1161/circulationaha.124.072156

BibTeX
@article{Reddy2025,
  author = {Reddy, Yogesh N V and Tada, Atsushi and Obokata, Masaru and Carter, Rickey E and Kaye, David M and Handoko, M Louis and Andersen, Mads J and Sharma, Kavita and Tedford, Ryan J and Redfield, Margaret M and Borlaug, Barry A},
  title = {Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient Setting},
  journal = {Circulation},
  year = {2025},
  volume = {151},
  number = {14},
  pages = {976--989},
  doi = {10.1161/circulationaha.124.072156}
}
Kostenlos starten →